SIRPant Immunotherapeutics Inc Appoints Jelle Kijlstra as Chief Medical Officer

SIRPant Immunotherapeutics Inc. announced the appointment of Jelle Kijlstra, MD, MBA as its new Chief Medical Officer. Dr. Jelle most recently worked at Sound Biologics as the Chief Medical Officer, where he focused on the development of checkpoint inhibitor combination therapy. With over 30 years of experience as a clinician-scientist and drug developer, he brings extensive expertise in cellular immunotherapy and clinical development.

SIRPant Immunotherapeutics Inc. is a biopharmaceutical company specializing in macrophage-based immunotherapies.